Deep Brain Stimulation for the Treatment of Obesity
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Deep Brain Stimulation Device
Sponsored by

About this trial
This is an interventional device feasibility trial for Obesity focused on measuring Obesity, DBS
Eligibility Criteria
Inclusion Criteria:
- At least 24 months post Roux-en-Y gastric bypass surgery without evidence of a sustained improvement in BMI after gastric bypass surgery for at least 6 months.
- Participant is willing to comply with all follow-up evaluations at the specified times
- Participant is able to provide informed consent
- Fluent in English
Exclusion Criteria:
- Medical contraindications for general anesthesia, craniotomy, or DBS surgery
- Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or subdural hematomas.
- Severe cardiovascular, pulmonary, renal, liver, hematological disease, severe coagulopathy, acute infectious process
Sites / Locations
- The Ohio State University Medical Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
DBS Surgery
Arm Description
All patients enrolled will undergo DBS implantation in the targeted region to assess the safety of the procedure and the efficacy through weight loss.
Outcomes
Primary Outcome Measures
Percentage of excess weight loss
The primary outcome measure at the conclusion of the study will be percent of excess weight loss (EWL).
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01512134
Brief Title
Deep Brain Stimulation for the Treatment of Obesity
Official Title
Deep Brain Stimulation For Morbid, Treatment-Refractory, Obesity
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
November 2016 (Actual)
Study Completion Date
November 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ali Rezai, MD
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option for obesity.
Detailed Description
The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option in the management of severe, treatment refractory, morbid obesity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Obesity, DBS
7. Study Design
Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
3 (Actual)
8. Arms, Groups, and Interventions
Arm Title
DBS Surgery
Arm Type
Experimental
Arm Description
All patients enrolled will undergo DBS implantation in the targeted region to assess the safety of the procedure and the efficacy through weight loss.
Intervention Type
Device
Intervention Name(s)
Deep Brain Stimulation Device
Other Intervention Name(s)
Reclaim
Intervention Description
Deep brain stimulation surgery
Primary Outcome Measure Information:
Title
Percentage of excess weight loss
Description
The primary outcome measure at the conclusion of the study will be percent of excess weight loss (EWL).
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
At least 24 months post Roux-en-Y gastric bypass surgery without evidence of a sustained improvement in BMI after gastric bypass surgery for at least 6 months.
Participant is willing to comply with all follow-up evaluations at the specified times
Participant is able to provide informed consent
Fluent in English
Exclusion Criteria:
Medical contraindications for general anesthesia, craniotomy, or DBS surgery
Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or subdural hematomas.
Severe cardiovascular, pulmonary, renal, liver, hematological disease, severe coagulopathy, acute infectious process
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ali Rezai, MD
Organizational Affiliation
Ohio State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Ohio State University Medical Center
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32140113
Citation
Weichart ER, Sederberg PB, Sammartino F, Krishna V, Corrigan JD, Rezai AR. Cognitive Task Performance During Titration Predicts Deep Brain Stimulation Treatment Efficacy: Evidence From a Case Study. Front Psychiatry. 2020 Feb 19;11:30. doi: 10.3389/fpsyt.2020.00030. eCollection 2020.
Results Reference
derived
Learn more about this trial
Deep Brain Stimulation for the Treatment of Obesity
We'll reach out to this number within 24 hrs